Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Crown LNG | CGBS | Apr 17, 2025 | 0.15 | 0.00 |
Cryo-Cell International | CCEL | Apr 17, 2025 | 5.82 | -3.48 |
CryoPort | CYRX | Apr 17, 2025 | 5.54 | -1.16 |
CS Disco | LAW | Apr 17, 2025 | 3.47 | +1.17 |
CSG Systems International | CSGS | Apr 17, 2025 | 60.44 | +1.07 |
CSP | CSPI | Apr 17, 2025 | 15.45 | +1.91 |
CSW Industrials | CSWI | Apr 17, 2025 | 298.43 | +1.04 |
CSX | CSX | Apr 17, 2025 | 27.68 | +1.21 |
CTO Realty Growth | CTO | Apr 17, 2025 | 18.14 | +0.83 |
CTO Realty Growth A Pref | CTO-A | Apr 17, 2025 | 19.90 | -1.85 |
CTRL Group | MCTR | Apr 17, 2025 | 7.51 | 0.00 |
CTS | CTS | Apr 17, 2025 | 37.58 | +2.15 |
CubeSmart | CUBE | Apr 17, 2025 | 39.57 | +2.86 |
Cue Biopharma | CUE | Apr 17, 2025 | 0.76 | -2.18 |
Cullen Frost Bankers B Pref | CFR-B | Apr 17, 2025 | 16.48 | -0.66 |
Cullen/Frost Bankers | CFR | Apr 17, 2025 | 111.60 | +0.37 |
Cullinan Therapeutics | CGEM | Apr 17, 2025 | 7.89 | +3.68 |
Culp | CULP | Apr 17, 2025 | 3.81 | +4.10 |
Cumberland Pharmaceuticals | CPIX | Apr 17, 2025 | 4.76 | +5.08 |
Cummins | CMI | Apr 17, 2025 | 281.81 | +0.45 |
Cumulus Media A | CMLS | Apr 17, 2025 | 0.25 | +4.56 |
Cuprina Holdings (Cayman) Limited - Ordinary shares | CUPR | Apr 17, 2025 | 4.95 | 0.00 |
Curbline Properties | CURB | Apr 17, 2025 | 23.18 | +1.93 |
Curevac N.V. | CVAC | Apr 17, 2025 | 3.12 | -2.50 |
CuriosityStream | CURI | Apr 17, 2025 | 3.17 | +8.93 |
Curis | CRIS | Apr 17, 2025 | 1.31 | +1.55 |
CURRENC Group | CURR | Apr 17, 2025 | 1.54 | +4.76 |
Curtiss-Wright | CW | Apr 17, 2025 | 318.48 | -0.47 |
Cushing Mlp & Infrastructure Total Return Fund | SRV | Apr 17, 2025 | 38.15 | +0.08 |
Cushman & Wakefield | CWK | Apr 17, 2025 | 8.28 | +1.60 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.